Turnstone Biologics Corp.
TSBX · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $2 | $0 |
| % Growth | – | -100% | – | – |
| Cost of Goods Sold | $0 | $0 | $1 | $1 |
| Gross Profit | $0 | -$0 | $1 | -$1 |
| % Margin | – | – | 50% | – |
| R&D Expenses | $0 | $4 | $8 | $14 |
| G&A Expenses | $5 | $5 | $3 | $4 |
| SG&A Expenses | $5 | $5 | $3 | $4 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $1 | $0 |
| Operating Expenses | $6 | $9 | $12 | $18 |
| Operating Income | -$6 | -$9 | -$11 | -$18 |
| % Margin | – | – | -563.8% | – |
| Other Income/Exp. Net | $0 | -$3 | -$1 | $1 |
| Pre-Tax Income | -$5 | -$12 | -$12 | -$18 |
| Tax Expense | $0 | $0 | $1 | -$1 |
| Net Income | -$5 | -$12 | -$13 | -$17 |
| % Margin | – | – | -637.9% | – |
| EPS | -0.24 | -0.51 | -0.56 | -0.74 |
| % Growth | 52.9% | 8.9% | 24.3% | – |
| EPS Diluted | -0.24 | -0.51 | -0.56 | -0.74 |
| Weighted Avg Shares Out | 23 | 23 | 23 | 23 |
| Weighted Avg Shares Out Dil | 23 | 23 | 23 | 23 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$6 | -$12 | -$11 | -$18 |
| % Margin | – | – | -547.1% | – |